179 related articles for article (PubMed ID: 31427232)
21. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
[TBL] [Abstract][Full Text] [Related]
22. MiR-708-5p is inversely associated with EWS/FLI1 Ewing sarcoma but does not represent a prognostic predictor.
Roberto GM; Vieira GM; Delsin LEA; Silva MO; Hakime RG; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Cancer Genet; 2019 Jan; 230():21-27. PubMed ID: 30470587
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of INK4A deletion in Ewing sarcoma.
Wei G; Antonescu CR; de Alava E; Leung D; Huvos AG; Meyers PA; Healey JH; Ladanyi M
Cancer; 2000 Aug; 89(4):793-9. PubMed ID: 10951342
[TBL] [Abstract][Full Text] [Related]
24. Suggested role for neutrophil extracellular trap formation in Ewing sarcoma immune microenvironment.
Shukrun R; Baron S; Fidel V; Shusterman A; Sher O; Kollender N; Levin D; Peled Y; Gortzak Y; Ben-Shahar Y; Caspi R; Gordon S; Manisterski M; Elhasid R
Cancer Sci; 2024 Jan; 115(1):36-47. PubMed ID: 37915266
[TBL] [Abstract][Full Text] [Related]
25. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U
Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574
[TBL] [Abstract][Full Text] [Related]
26. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells.
Riggi N; Suvà ML; De Vito C; Provero P; Stehle JC; Baumer K; Cironi L; Janiszewska M; Petricevic T; Suvà D; Tercier S; Joseph JM; Guillou L; Stamenkovic I
Genes Dev; 2010 May; 24(9):916-32. PubMed ID: 20382729
[TBL] [Abstract][Full Text] [Related]
27. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.
Sholl LM; Barletta JA; Yeap BY; Chirieac LR; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1193-8. PubMed ID: 20631605
[TBL] [Abstract][Full Text] [Related]
28. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
[TBL] [Abstract][Full Text] [Related]
29. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
[TBL] [Abstract][Full Text] [Related]
30. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
32. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
[TBL] [Abstract][Full Text] [Related]
33. Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma.
Davenport JR; Vo KT; Goldsby R; West DC; DuBois SG
Pediatr Blood Cancer; 2016 Jun; 63(6):1091-5. PubMed ID: 26891183
[TBL] [Abstract][Full Text] [Related]
34. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
[TBL] [Abstract][Full Text] [Related]
35. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
36. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract][Full Text] [Related]
37. The prognostic and therapeutic relevance of p27kip1 in Ewing's family tumors.
Matsunobu T; Tanaka K; Matsumoto Y; Nakatani F; Sakimura R; Hanada M; Li X; Oda Y; Naruse I; Hoshino H; Tsuneyoshi M; Miura H; Iwamoto Y
Clin Cancer Res; 2004 Feb; 10(3):1003-12. PubMed ID: 14871979
[TBL] [Abstract][Full Text] [Related]
38. Early blood-brain barrier dysfunction predicts neurological outcome following aneurysmal subarachnoid hemorrhage.
Lublinsky S; Major S; Kola V; Horst V; Santos E; Platz J; Sakowitz O; Scheel M; Dohmen C; Graf R; Vatter H; Wolf S; Vajkoczy P; Shelef I; Woitzik J; Martus P; Dreier JP; Friedman A
EBioMedicine; 2019 May; 43():460-472. PubMed ID: 31162113
[TBL] [Abstract][Full Text] [Related]
39. Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence.
Finicelli M; Benedetti G; Squillaro T; Pistilli B; Marcellusi A; Mariani P; Santinelli A; Latini L; Galderisi U; Giordano A
Oncotarget; 2014 Oct; 5(20):9678-88. PubMed ID: 25127259
[TBL] [Abstract][Full Text] [Related]
40. High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinoma.
Dai W; Tan X; Sun C; Zhou Q
Int J Mol Sci; 2014 May; 15(5):8393-406. PubMed ID: 24828201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]